The management of type 2 diabetes mellitus (T2DM) in older adults (aged ≥65 years) presents specific challenges. This Review summarizes the key age-related mechanisms contributing to T2DM and evaluates new evidence relating to frailty and sarcopenia, hypoglycaemia, comorbidities, and the implications for existing guidelines and therapeutic options.
- Srikanth Bellary
- Ioannis Kyrou
- Clifford J. Bailey
